Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
US9328087B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9328087-B2 |
| Application number | US-201314089050-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 25, 2013 |
| Priority date | Oct 10, 2008 |
| Publication date | May 3, 2016 |
| Grant date | May 3, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods of preparing a class of oxazolidinones useful to impede bacterial growth are disclosed.
Opening claim text (preview).
What is claimed is: 1. A compound of the formula: wherein: R 1 a and R 1 b are independently selected from H and F, provided that at least one of R 1 a and R 1 b is F, R 2 is selected from the group consisting of optionally substituted benzyl and optionally substituted C 1 -C 6 alkyl, and Het is tetrazolyl optionally substituted with methyl. 2. The compound of claim 1 wherein R 1 a is F and R 1 b is H. 3. The compound of claim 1 wherein Het is substituted with methyl. 4. The compound of claim 3 wherein Het is 2-methyl-tetrazol-5-yl. 5. The compound of claim 1 wherein R 2 is benzyl. 6. The compound of claim 1 wherein R 1 a is F, R 1 b is H, R 2 is benzyl, and Het is 2-methyl-tetrazol-5-yl. 7. The compound of claim 1 wherein the optionally substituted benzyl and the optionally substituted C 1 -C 6 alkyl are independently unsubstituted or substituted with halogen or C 1 -C 4 alkyloxy.
Antibacterial agents · CPC title
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title
linked by a carbon chain containing aromatic rings · CPC title
containing three or more hetero rings · CPC title
each of the hetero rings containing nitrogen as ring hetero atom · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.